- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/22 - Ribonucleases
Patent holdings for IPC class C12N 9/22
Total number of patents in this class: 12899
10-year publication summary
283
|
410
|
631
|
797
|
1015
|
1133
|
1243
|
1505
|
1790
|
1222
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 20035 |
543 |
The Broad Institute, Inc. | 1832 |
509 |
President and Fellows of Harvard College | 5992 |
461 |
Massachusetts Institute of Technology | 10093 |
459 |
Sangamo Therapeutics, Inc. | 418 |
170 |
The General Hospital Corporation | 4759 |
161 |
The Board of Trustees of the Leland Stanford Junior University | 6447 |
153 |
Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 310 |
149 |
Pairwise Plants Services, Inc. | 246 |
147 |
Cellectis | 406 |
143 |
CRISPR Therapeutics AG | 368 |
141 |
Arbor Biotechnologies Inc. | 167 |
140 |
Editas Medicine, Inc. | 253 |
137 |
Pioneer Hi-Bred International, Inc. | 6624 |
128 |
Beam Therapeutics Inc. | 240 |
119 |
Regeneron Pharmaceuticals, Inc. | 4312 |
114 |
Novozymes A/S | 3327 |
113 |
Duke University | 3084 |
113 |
Precision Biosciences, Inc. | 181 |
105 |
University of Massachusetts | 2233 |
101 |
Other owners | 8793 |